Abstract:EVAR is a feasible treatment in the majority of patients with ruptured or symptomatic AAA. The 30-day mortality appears to be similar between conventionally treated patients and those undergoing endovascular repair.
“…In recent years, the use of endovascular repair for ruptured AAA's has been on the rise [8]. In several studies, the feasibility and the effectiveness of EVAR in the reduction of short-term mortality has been documented [9][10] . One meta-analysis of over 50 years of data determined the overall mortality rate for open repair of ruptured AAA repair to be 48% [11].…”
“…In recent years, the use of endovascular repair for ruptured AAA's has been on the rise [8]. In several studies, the feasibility and the effectiveness of EVAR in the reduction of short-term mortality has been documented [9][10] . One meta-analysis of over 50 years of data determined the overall mortality rate for open repair of ruptured AAA repair to be 48% [11].…”
New search run. One new study included. No new studies excluded. Text updated to reflect current Cochrane standards. 'Summary of findings' table added. No change to conclusions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.